Moolec Science Q4 2024 GAAP EPS $(0.07) Misses $(0.06) Estimate, Sales $1.523M Beat $1.255M Estimate
Portfolio Pulse from Benzinga Newsdesk
Moolec Science reported its Q4 2024 financial results, with a GAAP EPS of $(0.07), missing the estimate of $(0.06). However, the company exceeded sales expectations, reporting $1.523 million compared to the estimated $1.255 million.
October 02, 2024 | 10:07 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Moolec Science's Q4 2024 earnings report showed a slight miss on EPS but a beat on sales. The EPS was $(0.07) against an estimate of $(0.06), while sales were $1.523M, surpassing the $1.255M estimate.
The mixed results, with a slight EPS miss but a sales beat, suggest a neutral short-term impact on MLEC's stock price. The sales beat may offset the negative sentiment from the EPS miss.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100